These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 34635158)
1. Individual and collective human intelligence in drug design: evaluating the search strategy. Cincilla G; Masoni S; Blobel J J Cheminform; 2021 Oct; 13(1):80. PubMed ID: 34635158 [TBL] [Abstract][Full Text] [Related]
2. Systemic evolutionary chemical space exploration for drug discovery. Lu C; Liu S; Shi W; Yu J; Zhou Z; Zhang X; Lu X; Cai F; Xia N; Wang Y J Cheminform; 2022 Apr; 14(1):19. PubMed ID: 35365231 [TBL] [Abstract][Full Text] [Related]
6. De novo drug design using multiobjective evolutionary graphs. Nicolaou CA; Apostolakis J; Pattichis CS J Chem Inf Model; 2009 Feb; 49(2):295-307. PubMed ID: 19434831 [TBL] [Abstract][Full Text] [Related]
7. Understanding Collective Intelligence: Investigating the Role of Collective Memory, Attention, and Reasoning Processes. Woolley AW; Gupta P Perspect Psychol Sci; 2024 Mar; 19(2):344-354. PubMed ID: 37642156 [TBL] [Abstract][Full Text] [Related]
8. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors. Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978 [TBL] [Abstract][Full Text] [Related]
9. [Artificial intelligence for future MD]. Sancipriano GP; Buttafarro M G Ital Nefrol; 2018 Dec; 35(6):. PubMed ID: 30550043 [TBL] [Abstract][Full Text] [Related]
11. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists. Bonnet P Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644 [TBL] [Abstract][Full Text] [Related]
13. REINVENT 2.0: An AI Tool for De Novo Drug Design. Blaschke T; Arús-Pous J; Chen H; Margreitter C; Tyrchan C; Engkvist O; Papadopoulos K; Patronov A J Chem Inf Model; 2020 Dec; 60(12):5918-5922. PubMed ID: 33118816 [TBL] [Abstract][Full Text] [Related]
14. Automated De Novo Drug Design: Are We Nearly There Yet? Schneider G; Clark DE Angew Chem Int Ed Engl; 2019 Aug; 58(32):10792-10803. PubMed ID: 30730601 [TBL] [Abstract][Full Text] [Related]
16. Chemical space exploration based on recurrent neural networks: applications in discovering kinase inhibitors. Li X; Xu Y; Yao H; Lin K J Cheminform; 2020 Jun; 12(1):42. PubMed ID: 33430983 [TBL] [Abstract][Full Text] [Related]
17. Comparative Accuracy of Diagnosis by Collective Intelligence of Multiple Physicians vs Individual Physicians. Barnett ML; Boddupalli D; Nundy S; Bates DW JAMA Netw Open; 2019 Mar; 2(3):e190096. PubMed ID: 30821822 [TBL] [Abstract][Full Text] [Related]
18. Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Reker D; Rodrigues T; Schneider P; Schneider G Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4067-72. PubMed ID: 24591595 [TBL] [Abstract][Full Text] [Related]
19. Structure design: an artificial intelligence-based method for the design of molecules under geometrical constraints. Cohen AA; Shatzmiller SE J Mol Graph; 1993 Sep; 11(3):166-73. PubMed ID: 8110662 [TBL] [Abstract][Full Text] [Related]
20. The quest for novel chemical matter and the contribution of computer-aided de novo design. Pirard B Expert Opin Drug Discov; 2011 Mar; 6(3):225-31. PubMed ID: 22647201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]